Journals / Ulusal Travma ve Acil Cerrahi Dergisi / 2008 / Cilt: 14 - Sayı: 2

Kritik kemik hasarlarında trombositce zengin plazma/kemik iliği kaynaklı stromal hücrelerin kompozitle enjekte edilerek tamir edilmesi: tavşanlarda deneysel çalışma

Repair of critical bone defects with injectable platelet rich plasma/bone marrow-derived stromal cells composite: experimental study in rabbits

Pages
87–95
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

RESULTS The results showed that repair of bone defect was the least in PRP alone group, and significant new bone formation could be observed in BMSCs/PRP group and particulate cancellous bone group, radiopacity area in BMSCs/PRP group attained 76.5%, which was in the same range of that in autogenous particulate cancellous bone group (82.4% in radiopacity area), compressive strength of engineered bone in BMSCs/PRP group attained 71% of that in autogenous particulate cancellous bone group (p<0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Platelet-rich plasma (PRP) has been applied to promote bone healing and developed as a novel material for bone regeneration.
📊
Key Findings & Data:This study aimed to investigate the feasibility of PRP carrier to deliver bone marrow derived stromal cells (BMSCs) and regenerate bone tissues to reconstruct critical bone defects in rabbits.
💡
Conclusion & Impact:RESULTS The results showed that repair of bone defect was the least in PRP alone group, and significant new bone formation could be observed in BMSCs/PRP group and particulate cancellous bone group, radiopacity area in BMSCs/PRP group attained 76.5%, which was in the same range of that in autogenous particulate cancellous bone group (82.4% in radiopacity area), compressive strength of engineered bone in BMSCs/PRP group attained 71% of that in autogenous particulate cancellous bone group (p<0.05).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kafatası kırıkları · Yönlendirilmiş doku yenilenmesi · Hastalık modelleri

Abstract

Platelet-rich plasma (PRP) has been applied to promote bone healing and developed as a novel material for bone regeneration. This study aimed to investigate the feasibility of PRP carrier to deliver bone marrow derived stromal cells (BMSCs) and regenerate bone tissues to reconstruct critical bone defects in rabbits. METHODS Critical sized defect were made on eighteen rabbits' crania and treated by different composites: BMSCs/PRP (n=6); Autogenous particulate cancellous bone group (n=6) and PRP alone group (n=6). The defects were evaluated by gross observation, radiographic examination, histological examination, and mechanical examination at 12 weeks postoperatively. RESULTS The results showed that repair of bone defect was the least in PRP alone group, and significant new bone formation could be observed in BMSCs/PRP group and particulate cancellous bone group, radiopacity area in BMSCs/PRP group attained 76.5%, which was in the same range of that in autogenous particulate cancellous bone group (82.4% in radiopacity area), compressive strength of engineered bone in BMSCs/PRP group attained 71% of that in autogenous particulate cancellous bone group (p<0.05). CONCLUSION These data implicated that BMSCs delivered from PRP gel can repair bony defect in immunocompetent animals, and the tissue engineered bone in BMSCs/PRP group is comparable to autogenous particulate cancellous bone group for the repair of critical-sized bone defect.

Özet

Trombositce zengin plazma (TZP), kemik iyileşmesine katkıda bulunmak üzere uygulanmış ve kemik yenilenmesine yönelik yeni bir materyal olarak geliştirilmiştir. Bu çalışmada tavşanlarda, kemik iliği kaynaklı stromal hücreler (KİKSH) vermek ve kritik kemik iliği hasarlarını düzeltmek için kemik dokularını yenilemek üzere TZP taşıyıcılığının fizibilitesinin incelenmesi amaçlandı. GEREÇ VE YÖNTEM On sekiz tavşamn kafatasına ciddi ölçüde hasar verildi ve bunlar değişik kompozitlerle tedavi edildi: KİKSH/TZP (n=6); otojen partiküler kansellöz kemik grubu (n=6) ve tek başına TZP grubu (n=6). Hasarlar, ameliyattan sonra 12. haftada gros gözlem, radyografik, histolojik ve mekanik incelemelerle değerlendirildi. BULGULAR Kemik hasarı tamirinin tek başına TZP grubunda en az düzeyde olduğunu, KİKSH/TZP grubu ile partiküler kansellöz kemik grubunda anlamlı yeni kemik oluşumu gözlenebileceğini, radyoopasite alanının KİKSH/TZP grubunda otojen partiküler kansellöz kemik grubundakinin (radyoopasite alanında %82.4) %76.5'i oranında kazanıldığını, planlanarak düzenlenmiş kemiğin kompresif gücünün KİKSH/TZP grubunda otojen partiküler kansellöz kemik grubundakinin %71 'i oranında kazanıldığını gösterdi (p<0.05). SONUÇ TZP jelden salıverilen KİKSH'lerin, bağışıklık sistemi normal olan hayvanlarda kemik hasarını tamir edebileceğini ve KİKSH/TZP grubundaki planlanarak düzenlenmiş kemiğin kritik ölçüdeki hasarının tamirinde otojen partiküler kansellöz kemik grubundaki ile karşılaştırılabilir olduğunu göstermiştir.

🔖

Cite This Article

CHENG, X., LEI, D., MAO, T., YANG, S., CHEN, F., WU, W. (2008). Kritik kemik hasarlarında trombositce zengin plazma/kemik iliği kaynaklı stromal hücrelerin kompozitle enjekte edilerek tamir edilmesi: tavşanlarda deneysel çalışma. Ulusal Travma ve Acil Cerrahi Dergisi, Cilt: 14 - Sayı: 2, 87–95. https://ajindex.com/articles/324781

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Wippermann BW, Schratt HE, Steeg S, Tscherne H. Complications of spongiosa harvesting of the ilial crest. A retrospective analysis of 1,191 cases. [Article in German] Chirurg 1997;68:1286-91
  2. Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000;21:2529-43
  3. Burg KJ, Porter S, Kellam JF. Biomaterial developments for bone tissue engineering. Biomaterials 2000;21:2347-59
  4. El-Ghannam A. Bone reconstruction: from bioceramics to tissue engineering. Expert Rev Med Devices 2005;2:87- 101
  5. Sittinger M, Hutmacher D W, Risbud MV. Current strategies for cell delivery in cartilage and bone regeneration. Curr Opin Biotechnol 2004; 15:411-8
  6. Chen F, Mao T, Tao K, Chen S, Ding G, Gu X. Injectable bone. Br J Oral Maxillofac Surg 2003;41:240-3
  7. Liu Y, Chen F, Liu W, Cui L, Shang Q, Xia W, et al. Repairing large porcine full-thickness defects of articular cartilage using autologous chondrocyte-engineered cartilage. Tissue Eng 2002;8:709-21
  8. Kulseng B, Skjâk-Braek G, Ryan L, Andersson A, King A, Faxvaag A, et al. Transplantation of alginate microcapsules: generation of antibodies against alginates and encapsulated porcine islet-like cell clusters. Transplantation 1999;67:978-84
  9. Temenoff JS, Park H, Jabbari E, Sheffield TL, LeBaron RG, Ambrose CG et al. In vitro osteogenic differentiation of marrow stromal cells encapsulated in biodegradable hydrogels. J Biomed Mater Res A 2004;70:235-44
  10. Spitzer RS, Perka C, Lindenhayn K, Zippel H. Matrix engineering for osteogenic differentiation of rabbit periosteal cells using alpha-tricalcium phosphate particles in a three-dimensional fibrin culture. J Biomed Mater Res 2002;59:690-6
  11. Sarkar MR, Augat P, Shefelbine SJ, Schorlemmer S, Huber-Lang M, Claes L, et al. Bone formation in a long bone defect model using a platelet-rich plasma-loaded collagen scaffold. Biomaterials 2006;27:1817-23
  12. Ferreira CF, Carriel Gomes MC, Filho JS, Granjeiro JM, Oliveira Simöes CM, Magini Rde S. Platelet-rich plasma influence on human osteoblasts growth. Clin Oral Implants Res 2005;16:456-60
  13. Kasten P, Vogel J, Luginbühl R, Niemeyer P, Weiss S, Schneider S, et al. Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics. Cells Tissues Organs 2006;183:68-79
  14. Yamada Y, Ueda M, Hibi H, Baba S. A novel approach to periodontal tissue regeneration with mesenchymal stem cells and platelet-rich plasma